Advancing Vaccines
For Better Lives

Welcome to Valneva

We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We have leveraged our expertise and capabilities both to commercialize three vaccines, including the world’s first and only chikungunya vaccine, and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease and Zika.

Learn More

Check out our 2023 Annual Business Report

Learn More

Follow Us

Today is #WorldHealthDay!

We’re advocating for the universal right to good health, so people can thrive wherever their adventures take them.
By developing #vaccines for #infectiousdiseases & #travel, we strive to help keep you safe and healthy.
Learn more:

#climatechange and disease, what's the connection? In a guest post from @valnevaSE Dr Juan Carlos Jaramillo we learn about the growing threat and how we can address it.
#vaccinenation #vaccine #vaccines #disease #infectiousdisease #globalhealth #valneva

Today's the last day of #WVCDC. It's been inspiring to share and learn more about some incredible strides in vaccine #innovation.
The Valneva team are still here at booth 433 – stop by for more on our mission and initiatives.
#Vaccines #WVCUSA @vaccinenation


Load More